Raman Spectroscopy and Machine Learning for IDH Genotyping of Unprocessed Glioma Biopsies
Isocitrate dehydrogenase (IDH) mutational status is pivotal in the management of gliomas. Patients with IDH-mutated (IDH-MUT) tumors have a better prognosis and benefit more from extended surgical resection than IDH wild-type (IDH-WT). Raman spectroscopy (RS) is a minimally invasive optical techniqu...
Main Authors: | Tommaso Sciortino, Riccardo Secoli, Ester d’Amico, Sara Moccia, Marco Conti Nibali, Lorenzo Gay, Marco Rossi, Nicolò Pecco, Antonella Castellano, Elena De Momi, Bethania Fernandes, Marco Riva, Lorenzo Bello |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-08-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/16/4196 |
Similar Items
-
IDH1/IDH2 Inhibition in Acute Myeloid Leukemia
by: Claudio Cerchione, et al.
Published: (2021-03-01) -
Glioma <i>biopsies</i> Classification Using Raman Spectroscopy and Machine Learning Models on Fresh Tissue Samples
by: Marco Riva, et al.
Published: (2021-03-01) -
Promoter methylation analysis of IDH genes in human gliomas
by: Simon eFlanagan, et al.
Published: (2012-12-01) -
<i>IDH</i> Mutations in Glioma: Double-Edged Sword in Clinical Applications?
by: Alisan Kayabolen, et al.
Published: (2021-07-01) -
Molecular alterations of isocitrate dehydrogenase 1 and 2 (<it>IDH1 </it>and <it>IDH2</it>) metabolic genes and additional genetic mutations in newly diagnosed acute myeloid leukemia patients
by: Chotirat Sadudee, et al.
Published: (2012-03-01)